135 related articles for article (PubMed ID: 8263100)
21. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
[TBL] [Abstract][Full Text] [Related]
22. Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis.
Ellard GA; Humphries MJ; Gabriel M; Teoh R
Br Med J (Clin Res Ed); 1987 Jan; 294(6567):284-5. PubMed ID: 3101843
[No Abstract] [Full Text] [Related]
23. Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
Ramachandran G; Chandrasekaran V; Hemanth Kumar AK; Dewan P; Swaminathan S; Thomas A
Trop Med Int Health; 2013 Sep; 18(9):1141-1144. PubMed ID: 23937703
[TBL] [Abstract][Full Text] [Related]
24. Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation.
Calleri E; De Lorenzi E; Furlanetto S; Massolini G; Caccialanza G
J Pharm Biomed Anal; 2002 Aug; 29(6):1089-96. PubMed ID: 12110394
[TBL] [Abstract][Full Text] [Related]
25. Quantification of pyrazinamide, isoniazid, acetyl-isoniazid, and rifampicin by a high-performance liquid chromatography method in human plasma from patients with tuberculosis.
Hernández-González O; Zarazúa S; Veytia-Bucheli JI; González-Chávez MM; Rodríguez-Pinal CJ; Medellín-Garibay SE; Uresti-Rivera EE; Pérez-Vázquez FJ; Portales-Pérez DP; Romano-Moreno S; Milán-Segovia RDC
J Sep Sci; 2021 Jan; 44(2):521-529. PubMed ID: 33200497
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis.
Donald PR; Seifart HI
J Pediatr; 1989 Sep; 115(3):483-6. PubMed ID: 2769511
[TBL] [Abstract][Full Text] [Related]
27. [Identification and determination of antitubercular compounds].
Iwainsky H; Grunert M; Reutgen H; Sehrt I
Pharmazie; 1970 Sep; 25(9):505-13. PubMed ID: 4922351
[No Abstract] [Full Text] [Related]
28. Development and Validation of an HPLC Method for Simultaneous Determination of Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol Hydrochloride in Pharmaceutical Formulations.
Chellini PR; Lages EB; Franco PH; Nogueira FH; César IC; Pianetti GA
J AOAC Int; 2015; 98(5):1234-9. PubMed ID: 26525241
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous determination of isoniazid, pyrazinamide, rifampicin and acetylisoniazid in human plasma by high-performance liquid chromatography.
Zhou Z; Chen L; Liu P; Shen M; Zou F
Anal Sci; 2010; 26(11):1133-8. PubMed ID: 21079341
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis.
Ellard GA; Humphries MJ; Allen BW
Am Rev Respir Dis; 1993 Sep; 148(3):650-5. PubMed ID: 8368635
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid pyrazinamide concentrations in children with tuberculous meningitis.
Donald PR; Seifart H
Pediatr Infect Dis J; 1988 Jul; 7(7):469-71. PubMed ID: 3405648
[TBL] [Abstract][Full Text] [Related]
32. Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Park JS; Lee JY; Lee YJ; Kim SJ; Cho YJ; Yoon HI; Lee CT; Song J; Lee JH
Antimicrob Agents Chemother; 2016 Jan; 60(1):92-8. PubMed ID: 26459901
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
Song SH; Jun SH; Park KU; Yoon Y; Lee JH; Kim JQ; Song J
Rapid Commun Mass Spectrom; 2007; 21(7):1331-8. PubMed ID: 17340570
[TBL] [Abstract][Full Text] [Related]
34. High-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethionamide in human plasma, bronchoalveolar lavage fluid and alveolar cells.
Conte JE; Wang G; Lin ET; Zurlinden E
J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):343-53. PubMed ID: 11334350
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
Mohan B; Sharda N; Singh S
J Pharm Biomed Anal; 2003 Mar; 31(3):607-12. PubMed ID: 12615251
[TBL] [Abstract][Full Text] [Related]
36. Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids.
Gennaro MC; Calvino R; Abrigo C
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):477-86. PubMed ID: 11339291
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination of rifampicin, isoniazid and pyrazinamide in tablet preparations by multivariate spectrophotometric calibration.
Goicoechea HC; Olivieri AC
J Pharm Biomed Anal; 1999 Aug; 20(4):681-6. PubMed ID: 10704137
[TBL] [Abstract][Full Text] [Related]
38. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
39. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.
Fahimi F; Tabarsi P; Kobarfard F; Bozorg BD; Goodarzi A; Dastan F; Shahsavari N; Emami S; Habibi M; Salamzadeh J
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1602-6. PubMed ID: 24200276
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status.
Donald PR; Gent WL; Seifart HI; Lamprecht JH; Parkin DP
Pediatrics; 1992 Feb; 89(2):247-50. PubMed ID: 1734391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
